Back to FARALLON CAPITAL MANAGEMENT, L.L.C.

PCVX
5 quarters

Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in VAXCYTE INC

FARALLON CAPITAL MANAGEMENT, L.L.C. holds 1.3M shares of PCVX (VAXCYTE INC), worth $73.3M as of 2026-Q1. The position was increased (+251x shares). PCVX represents 0.4% of FARALLON CAPITAL MANAGEMENT, L.L.C.'s portfolio.

Current Value

$73.3M

Current Shares

1.3M

Total Value Change

+$51.4M

Total Shares Change

+971,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.3M
+251x
$73.3M0.4%$59.82
57
2025-Q4
New
5,000
-
$230,7000.0%$45.41
32
2024-Q4
Exited
0
-100.0%
$00.0%$81.99
0
2024-Q3
Decreased
28,000
-90.3%
$3.2M0.0%$113.14
0
2024-Q2
Decreased
290,000
-23.2%
$21.9M0.1%$75.51
0

Other major holders of PCVX: VANGUARD GROUP INC, Janus Henderson Group Ltd., FMR LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used